Study protocol for a type III hybrid effectiveness-implementation trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care.

Behavioral economics Evidence-based practice Firearm safety promotion Hybrid effectiveness-implementation trials Implementation science Pediatrics Primary care Violence prevention

Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
22 09 2021
Historique:
received: 09 08 2021
accepted: 24 08 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 26 11 2021
Statut: epublish

Résumé

Insights from behavioral economics, or how individuals' decisions and behaviors are shaped by finite cognitive resources (e.g., time, attention) and mental heuristics, have been underutilized in efforts to increase the use of evidence-based practices in implementation science. Using the example of firearm safety promotion in pediatric primary care, which addresses an evidence-to-practice gap in universal suicide prevention, we aim to determine: is a less costly and more scalable behavioral economic-informed implementation strategy (i.e., "Nudge") powerful enough to change clinician behavior or is a more intensive and expensive facilitation strategy needed to overcome implementation barriers? The Adolescent and child Suicide Prevention in Routine clinical Encounters (ASPIRE) hybrid type III effectiveness-implementation trial uses a longitudinal cluster randomized design. We will test the comparative effectiveness of two implementation strategies to support clinicians' use of an evidence-based firearm safety practice, S.A.F.E. Firearm, in 32 pediatric practices across two health systems. All pediatric practices in the two health systems will receive S.A.F.E. Firearm materials, including training and cable locks. Half of the practices (k = 16) will be randomized to receive Nudge; the other half (k = 16) will be randomized to receive Nudge plus 1 year of facilitation to target additional practice and clinician implementation barriers (Nudge+). The primary implementation outcome is parent-reported clinician fidelity to the S.A.F.E Firearm program. Secondary implementation outcomes include reach and cost. To understand how the implementation strategies work, the primary mechanism to be tested is practice adaptive reserve, a self-report practice-level measure that includes relationship infrastructure, facilitative leadership, sense-making, teamwork, work environment, and culture of learning. The ASPIRE trial will integrate implementation science and behavioral economic approaches to advance our understanding of methods for implementing evidence-based firearm safety promotion practices in pediatric primary care. The study answers a question at the heart of many practice change efforts: which strategies are sufficient to support change, and why? Results of the trial will offer valuable insights into how best to implement evidence-based practices that address sensitive health matters in pediatric primary care. ClinicalTrials.gov, NCT04844021 . Registered 14 April 2021.

Sections du résumé

BACKGROUND
Insights from behavioral economics, or how individuals' decisions and behaviors are shaped by finite cognitive resources (e.g., time, attention) and mental heuristics, have been underutilized in efforts to increase the use of evidence-based practices in implementation science. Using the example of firearm safety promotion in pediatric primary care, which addresses an evidence-to-practice gap in universal suicide prevention, we aim to determine: is a less costly and more scalable behavioral economic-informed implementation strategy (i.e., "Nudge") powerful enough to change clinician behavior or is a more intensive and expensive facilitation strategy needed to overcome implementation barriers?
METHODS
The Adolescent and child Suicide Prevention in Routine clinical Encounters (ASPIRE) hybrid type III effectiveness-implementation trial uses a longitudinal cluster randomized design. We will test the comparative effectiveness of two implementation strategies to support clinicians' use of an evidence-based firearm safety practice, S.A.F.E. Firearm, in 32 pediatric practices across two health systems. All pediatric practices in the two health systems will receive S.A.F.E. Firearm materials, including training and cable locks. Half of the practices (k = 16) will be randomized to receive Nudge; the other half (k = 16) will be randomized to receive Nudge plus 1 year of facilitation to target additional practice and clinician implementation barriers (Nudge+). The primary implementation outcome is parent-reported clinician fidelity to the S.A.F.E Firearm program. Secondary implementation outcomes include reach and cost. To understand how the implementation strategies work, the primary mechanism to be tested is practice adaptive reserve, a self-report practice-level measure that includes relationship infrastructure, facilitative leadership, sense-making, teamwork, work environment, and culture of learning.
DISCUSSION
The ASPIRE trial will integrate implementation science and behavioral economic approaches to advance our understanding of methods for implementing evidence-based firearm safety promotion practices in pediatric primary care. The study answers a question at the heart of many practice change efforts: which strategies are sufficient to support change, and why? Results of the trial will offer valuable insights into how best to implement evidence-based practices that address sensitive health matters in pediatric primary care.
TRIAL REGISTRATION
ClinicalTrials.gov, NCT04844021 . Registered 14 April 2021.

Identifiants

pubmed: 34551811
doi: 10.1186/s13012-021-01154-8
pii: 10.1186/s13012-021-01154-8
pmc: PMC8456701
doi:

Banques de données

ClinicalTrials.gov
['NCT04844021']

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

89

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH123491
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH109433
Pays : United States
Organisme : NIMH NIH HHS
ID : U19 MH092201
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Pediatrics. 2008 Jul;122(1):e15-25
pubmed: 18595960
Stat Med. 2010 Sep 10;29(20):2117-25
pubmed: 20658478
Front Public Health. 2018 May 07;6:136
pubmed: 29868544
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Stat Med. 2006 Aug 30;25(16):2720-36
pubmed: 16345043
Adm Policy Ment Health. 2011 Jan;38(1):44-53
pubmed: 20967495
J Gen Intern Med. 2014 Dec;29 Suppl 4:904-12
pubmed: 25355087
J Pediatr Surg. 2012 Jun;47(6):1196-203
pubmed: 22703793
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
JAMA Pediatr. 2019 Aug 1;173(8):780-789
pubmed: 31180470
Clin Trials. 2004;1(3):297-305
pubmed: 16279255
JAMA Intern Med. 2016 Jun 1;176(6):847-8
pubmed: 27159011
J Gen Intern Med. 2012 Nov;27(11):1544-7
pubmed: 22549296
Transl Behav Med. 2011 Sep 1;1(3):427-435
pubmed: 22081776
Annu Rev Clin Psychol. 2007;3:1-27
pubmed: 17716046
Front Public Health. 2019 Jun 18;7:158
pubmed: 31275915
Implement Sci Commun. 2020 Sep 28;1:81
pubmed: 33005900
PLoS One. 2020 May 5;15(5):e0232076
pubmed: 32369511
J Consult Clin Psychol. 2016 Aug;84(8):713-25
pubmed: 27253202
Med J Aust. 2004 Mar 15;180(S6):S57-60
pubmed: 15012583
Psychiatry Res. 2020 Jan;283:112433
pubmed: 31202612
JAMA Pediatr. 2018 Jul 1;172(7):697-699
pubmed: 29799931
Death Stud. 2015;39(10):600-4
pubmed: 26083790
NCHS Data Brief. 2012 Dec;(111):1-8
pubmed: 23384787
Natl Vital Stat Rep. 2018 Jun;67(4):1-16
pubmed: 29874162
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
Adm Policy Ment Health. 2016 Nov;43(6):834-849
pubmed: 27480546
BMJ Open. 2021 Jul 12;11(7):e048801
pubmed: 34253672
Pediatrics. 1995 Oct;96(4 Pt 1):649-53
pubmed: 7567325
JAMA. 2016 Feb 9;315(6):562-70
pubmed: 26864410
Ann Behav Med. 2009 Apr;37(2):218-27
pubmed: 19291342
J Gen Intern Med. 2013 Dec;28(12):1581-8
pubmed: 23733374
J Child Psychol Psychiatry. 2019 Apr;60(4):430-450
pubmed: 30144077
Suicide Life Threat Behav. 2019 Aug;49(4):1105-1118
pubmed: 30091246
J Gen Intern Med. 2017 Jul;32(7):790-795
pubmed: 28337690
Adm Policy Ment Health. 2015 Nov;42(6):672-81
pubmed: 25315183
Inj Prev. 2007 Apr;13(2):99-104
pubmed: 17446249
Am J Public Health. 2000 Dec;90(12):1885-91
pubmed: 11111261
JAMA Pediatr. 2019 Jul 1;173(7):657-662
pubmed: 31081861
J Clin Epidemiol. 2018 Aug;100:92-102
pubmed: 29660481
EGEMS (Wash DC). 2018 May 25;6(1):10
pubmed: 30094282
Inj Epidemiol. 2020 Feb 3;7(1):4
pubmed: 32127045
BMJ Open. 2017 Jun 24;7(6):e014407
pubmed: 28647722
Psychiatr Serv. 2021 Jul 29;:appips202000419
pubmed: 34320822
Paediatr Child Health. 2008 Jan;13(1):53-60
pubmed: 19119355
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Implement Sci. 2016 Jul 04;11(1):88
pubmed: 27377404
Curr Probl Pediatr Adolesc Health Care. 2014 Jul;44(6):170-81
pubmed: 24981666
N Engl J Med. 2018 Dec 20;379(25):2468-2475
pubmed: 30575483
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
JAMA Psychiatry. 2021 Sep 1;78(9):941-942
pubmed: 34076686
Implement Sci. 2017 Mar 3;12(1):29
pubmed: 28253900
Multivariate Behav Res. 2001 Apr 1;36(2):249-77
pubmed: 26822111
Am J Public Health. 2013 Jun;103(6):e38-46
pubmed: 23597377
Ann Fam Med. 2012 Jan-Feb;10(1):63-74
pubmed: 22230833
J Clin Child Adolesc Psychol. 2015;44(1):1-29
pubmed: 25256034
Ann Fam Med. 2010;8 Suppl 1:S33-44; S92
pubmed: 20530393
J Urban Health. 2018 Jun;95(3):295-304
pubmed: 29748766
J Behav Med. 2019 Aug;42(4):691-701
pubmed: 31367934
Acad Pediatr. 2021 Sep-Oct;21(7):1161-1170
pubmed: 33901726
N Engl J Med. 2018 Jan 18;378(3):214-216
pubmed: 29342387
JAMA Pediatr. 2015 Jul;169(7):673-7
pubmed: 25984947
Implement Sci. 2014 Aug 12;9:102
pubmed: 25112492
Cancer. 2015 Apr 15;121(8):1241-8
pubmed: 25524651
Health Aff (Millwood). 2016 Aug 1;35(8):1504-12
pubmed: 27503977
Psychol Methods. 2002 Mar;7(1):83-104
pubmed: 11928892
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Implement Sci. 2008 May 16;3:26
pubmed: 18485219
JMIR Res Protoc. 2019 Feb 12;8(2):e12121
pubmed: 30747719
Ann Intern Med. 2014 Jan 21;160(2):101-10
pubmed: 24592495
AMA J Ethics. 2020 Sep 1;22(9):E796-801
pubmed: 33009777
Epidemiol Rev. 2016;38(1):111-24
pubmed: 26769724
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
Annu Rev Public Health. 2012 Apr;33:393-408
pubmed: 22224886
JAMA Netw Open. 2018 Jul 6;1(3):e180818
pubmed: 30646039
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
JAMA Netw Open. 2018 Nov 2;1(7):e185309
pubmed: 30646398
Acad Pediatr. 2019 Aug;19(6):670-676
pubmed: 30508600
Pers Soc Psychol Bull. 2017 Aug;43(8):1071-1085
pubmed: 28903713
Pediatrics. 2018 Jun;141(6):
pubmed: 29769243
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683

Auteurs

Rinad S Beidas (RS)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. rinad.beidas@pennmedicine.upenn.edu.

Brian K Ahmedani (BK)

Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.

Kristin A Linn (KA)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Steven C Marcus (SC)

School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, USA.

Christina Johnson (C)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Melissa Maye (M)

Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.

Joslyn Westphal (J)

Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.

Leslie Wright (L)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.

Arne L Beck (AL)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.

Alison M Buttenheim (AM)

School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.

Matthew F Daley (MF)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.

Molly Davis (M)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marisa E Elias (ME)

Department of Pediatrics, Henry Ford Health System, Detroit, MI, USA.

Shari Jager-Hyman (S)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Katelin Hoskins (K)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Adina Lieberman (A)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Bridget McArdle (B)

Department of Pediatrics, Henry Ford Health System, Detroit, MI, USA.

Debra P Ritzwoller (DP)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.

Dylan S Small (DS)

Wharton School of Business, University of Pennsylvania, Philadelphia, PA, USA.

Courtney Benjamin Wolk (CB)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Nathaniel J Williams (NJ)

School of Social Work, Boise State University, Boise, ID, USA.

Jennifer M Boggs (JM)

Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH